We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$585B
AUM Growth
+$29.3B
Cap. Flow
+$1.02B
Cap. Flow %
0.17%
Top 10 Hldgs %
17.95%
Holding
2,642
New
88
Increased
1,025
Reduced
900
Closed
73

Top Buys

Rank Stock Value
1
GEN icon
Gen Digital
GEN
+$2.03B
2
DD icon
DuPont de Nemours
DD
+$1.83B
3
CCI icon
Crown Castle
CCI
+$1.58B
4
MSFT icon
Microsoft
MSFT
+$1.48B
5
TRU icon
TransUnion
TRU
+$781M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.53%
3 Technology 15%
4 Consumer Discretionary 13.37%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAIC
2376
DELISTED
Arlington Asset Investment Corp.
AAIC
$220K ﹤0.01%
17,285
EFSC icon
2377
Enterprise Financial Services Corp
EFSC
$2.41B
$219K ﹤0.01%
5,163
+3
+0.1% +$119
EVRI
2378
DELISTED
Everi Holdings
EVRI
$219K ﹤0.01%
28,879
SPOK icon
2379
Spok Holdings
SPOK
$231M
$219K ﹤0.01%
14,264
ATNI icon
2380
ATN International
ATNI
$474M
$218K ﹤0.01%
4,137
RSO
2381
DELISTED
Resource Capital Corp.
RSO
$218K ﹤0.01%
20,250
-9,800
-33% -$101K
OLP
2382
One Liberty Properties
OLP
$522M
$217K ﹤0.01%
8,899
MED icon
2383
Medifast
MED
$131M
$216K ﹤0.01%
+3,630
New +$181K
AXDX
2384
DELISTED
Accelerate Diagnostics
AXDX
$215K ﹤0.01%
+957
New +$235K
CRR
2385
DELISTED
Carbo Ceramics Inc.
CRR
$215K ﹤0.01%
24,936
PIR
2386
DELISTED
Pier 1 Imports, Inc.
PIR
$213K ﹤0.01%
2,546
BCE icon
2387
BCE
BCE
$21.5B
$211K ﹤0.01%
4,508
-77
-2% -$3.6K
EHTH icon
2388
eHealth
EHTH
$40M
$211K ﹤0.01%
+8,844
New +$180K
FC icon
2389
Franklin Covey
FC
$233M
$210K ﹤0.01%
10,332
ANCX
2390
DELISTED
Access National Corp
ANCX
$210K ﹤0.01%
+7,339
New +$192K
DXPE icon
2391
DXP Enterprises
DXPE
$3.02B
$209K ﹤0.01%
+6,643
New +$198K
GORO icon
2392
Goldgroup Mining Inc.
GORO
$207M
$208K ﹤0.01%
55,399
+100
+0.2% +$390
IDT icon
2393
IDT Corp
IDT
$1.61B
$208K ﹤0.01%
17,485
IVAC
2394
DELISTED
Intevac Inc
IVAC
$208K ﹤0.01%
24,655
WMGIZ
2395
DELISTED
Wright Medical Group, Inc. Contingent Value Right
WMGIZ
$208K ﹤0.01%
132,507
ACU icon
2396
Acme United Corp
ACU
$224M
$207K ﹤0.01%
9,000
AMSF icon
2397
AMERISAFE
AMSF
$517M
$207K ﹤0.01%
3,553
GIFI
2398
DELISTED
Gulf Island Fabrication
GIFI
$206K ﹤0.01%
16,238
OPCH icon
2399
Option Care Health
OPCH
$3.55B
$206K ﹤0.01%
18,750
+25
+0.1% +$282
SCMP
2400
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$205K ﹤0.01%
17,373
+6,900
+66% +$77.4K

Similar funds

T. Rowe Price Associates's Q3 2017 Portfolio in Review

As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.

  • T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
  • T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
  • T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
  • T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
  • T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
  • T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
  • T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.

Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.